Every Form 4 that Orchid Island Capital, Inc. (ORC) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow ORC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ORC filings page.
Orchid Island Capital, Inc. (symbol: ORC) is the issuer of record for a Form 4 filing submitted to the SEC.
Parker Ava L reported acquisition or exercise transactions in this Form 4 filing.
Orchid Island Capital director Ava L. Parker received a grant of 1,791 Deferred Stock Units on July 31, 2026, at $6.63 per unit. Each unit represents the right to receive one share of common stock and was issued in lieu of the company’s monthly dividend under her election. The units are 100% vested but become payable only upon a change of control or Parker’s death, disability, or separation from service as a director. Following this award, she holds 124,131 deferred stock units.
FILIPPS FRANK P reported acquisition or exercise transactions in this Form 4 filing.
Orchid Island Capital director Frank P. Filipps received a grant of deferred stock units as part of his director compensation. On this date, he was awarded 3,586 deferred stock units, each representing the right to receive one share of Orchid Island Capital common stock.
These deferred stock units are fully vested but will only be paid out upon a change of control of the company or upon his death, disability, or separation from service as a director. Following this award, Filipps directly holds 53,875 deferred stock units linked to the company’s common stock.
Orchid Island Capital director Ava L. Parker reported two routine compensation-related awards of deferred stock units. On June 30, 2026, she acquired 1,679 deferred stock units at a reference price of 6.9700 per unit, and on July 1, 2026 she acquired an additional 3,586 units at no cost. Each deferred stock unit represents a right to receive one share of Orchid Island Capital common stock and is fully vested. These units were issued in lieu of the company’s monthly dividend under Parker’s election and become payable only upon a change of control or upon her death, disability, or separation from service as a director. Following these awards, she holds 122,340 deferred stock units directly.
Morabito Paula reported acquisition or exercise transactions in this Form 4 filing.
Orchid Island Capital, Inc. director Paula Morabito received a grant of 3,586 Deferred Stock Units as compensation. Each unit represents the right to receive one share of common stock and is fully vested. These units become payable only upon a change of control or upon her death, disability, or separation from service as a director. Following this award, she holds a total of 55,686 Deferred Stock Units directly.
Bitting W Coleman reported acquisition or exercise transactions in this Form 4 filing.
Orchid Island Capital director W. Coleman Bitting received a grant of 3,586 deferred stock units as compensation. Each unit represents the right to receive one share of common stock. Following this award, he holds 53,875 deferred stock units. The units are fully vested but only become payable upon a change of control or his death, disability, or separation from service as a director.
Orchid Island Capital CEO Robert E. Cauley exercised performance-based equity awards into 3,694 shares of common stock, stemming from Performance Units granted in 2023 and 2024. Following these vestings, he directly holds 226,984 common shares and 126,995.38 Performance Units, reflecting routine compensation-related equity activity.
Orchid Island Capital Chief Financial Officer Haas G. Hunter IV reported routine equity compensation activity involving performance units and common stock. On June 26, 2026, he exercised performance units to acquire 3,031 shares of common stock at $0.00 per share under the company’s equity incentive plans. In connection with this vesting, 1,193 shares of common stock were transferred back to the issuer at $6.86 per share to cover tax withholding obligations, which is not an open-market sale. After these transactions, he directly held 137,522 shares of common stock and 97,939.95 performance units.
Parker Ava L reported acquisition or exercise transactions in this Form 4 filing.
Orchid Island Capital director Ava L. Parker reported receiving 1,660 Deferred Stock Units, each representing the right to receive one share of common stock. These units were issued at a reference price of $6.95 per unit.
The award reflects Parker’s election to receive the issuer’s monthly dividend in the form of deferred stock units rather than cash. The units are 100% vested but will only be paid out upon a change of control or upon Parker’s death, disability, or separation from service as a director. Following this grant, Parker holds 117,075 Deferred Stock Units.
Orchid Island Capital director Ava L. Parker received 1,877 deferred stock units as a grant in an acquisition-type transaction. The units were issued on April 30, 2026 in lieu of the company’s monthly cash dividend, based on a reference price of $7.03 per unit.
Each deferred stock unit represents the right to receive one share of Orchid Island’s common stock. The units are fully vested, and Parker now holds 115,415 deferred stock units. However, these units will only be paid out in shares upon a change of control or upon her death, disability, or separation from service as a director.
FILIPPS FRANK P reported acquisition or exercise transactions in this Form 4 filing.
Orchid Island Capital director Frank P. Filipps received a grant of 3,561 deferred stock units. These units are fully vested and each represents the right to receive one share of common stock. They will be paid only upon a change of control or his death, disability, or separation from service as a director. Following the award, he holds 50,289 deferred stock units in total, reflecting routine non-cash director compensation rather than an open-market share purchase or sale.
Bitting W Coleman reported acquisition or exercise transactions in this Form 4 filing.
Orchid Island Capital director Bitting W. Coleman received a routine equity award in the form of deferred stock units. The grant covers 3,561 deferred stock units at a price of $0.00 per unit, each representing the right to receive one share of common stock. Following this award, Coleman holds 50,289 deferred stock units. The units are fully vested but will only be paid in shares upon a change of control or Coleman's death, disability, or separation from service as a director.
Morabito Paula reported acquisition or exercise transactions in this Form 4 filing.
Orchid Island Capital director Paula Morabito received 3,561 deferred stock units as a compensation award. Each unit represents the right to receive one share of common stock, bringing her total deferred stock units to 52,100 held directly.
The units are fully vested but will only be paid out in shares upon a change of control of Orchid Island Capital, or upon her death, disability, or separation from service as a director. This filing reflects a routine grant rather than an open-market purchase or sale.
Orchid Island Capital director Ava L. Parker reported awards of deferred stock units that increase her equity-based compensation. On March 30, she acquired 1,877 deferred stock units, and on April 1 she acquired 3,561 deferred stock units, each representing one share of common stock.
The units are fully vested but only payable upon a change of control or her death, disability, or separation from service as a director. Following these awards, Parker holds 113,538 deferred stock units, reflecting a larger, long-term alignment with shareholders rather than open-market trading.
Orchid Island Capital Chief Financial Officer Haas G. Hunter IV exercised performance-based equity awards into common stock. On March 26, 2026, 3,031.72 Performance Units were converted into 3,031 shares of common stock, reflecting vesting of awards granted in April 2023 and March 2024.
To cover tax withholding tied to this vesting, 1,133 shares were returned to the company at a price of $7.15 per share, equal to the March 25, 2026 closing price. Following these compensation-related transactions, Hunter directly holds 135,684 shares of Orchid Island Capital common stock.
Orchid Island Capital CEO Robert E. Cauley exercised performance-based equity awards, receiving 3,694 shares of common stock at a stated price of $0.0000 per share. The transaction reflects the vesting of previously granted Performance Units under the company’s equity incentive plans.
Following these transactions, Cauley directly holds 223,290 shares of Orchid Island Capital common stock. Cash was paid instead of issuing fractional shares, based on the closing share price on March 25, 2026, indicating this is a routine, compensation-related equity settlement rather than an open-market trade.
Orchid Island Capital CEO Robert E. Cauley reported routine equity compensation and related tax withholding. He was granted 121,891 performance units, each representing a contingent right to one share of common stock, under the company’s 2021 and 2025 long-term incentive plans.
On the same date, he also received 121,891 unrestricted common shares, and 49,790 common shares were disposed back to the company at a value of $6.82 per share to satisfy tax withholding obligations. After these transactions, he held 219,596 shares of common stock directly.
Orchid Island Capital Chief Financial Officer Haas G. Hunter IV reported equity compensation awards and related tax withholding transactions. He was granted 93,184 performance units, each representing a contingent right to receive one share of common stock, bringing his performance unit balance to 104,003.39 units.
On the same date, he also received 93,184 unrestricted shares of common stock at no cost under the company’s equity incentive plans. To satisfy tax withholding obligations from this share award, 36,896 common shares were disposed of back to the company at a price of $6.82 per share, based on the March 20, 2026 closing price.
Following these transactions, Hunter directly owns 133,786 shares of Orchid Island Capital common stock, in addition to his outstanding performance units. The filing reflects routine compensation-related grants and associated tax withholding, rather than open-market purchases or sales.
Orchid Island Capital director Ava L. Parker reported an acquisition of 1,680 deferred stock units on February 27, 2026, valued at $7.60 per unit. Her direct holdings in this derivative security increased to 108,100 deferred stock units after the transaction.
Each deferred stock unit represents a right to receive one share of Orchid Island Capital common stock. The units are fully vested but will only be paid out upon a change of control or Parker’s death, disability, or separation from service as a director. They were issued in lieu of the company’s monthly dividend under her prior election.
Orchid Island Capital, Inc. director Ava L. Parker reported acquiring 1,559 deferred stock units on 01/30/2026. Each deferred stock unit represents a right to receive one share of Orchid Island’s common stock and was valued at $7.80 per unit.
The units were issued in lieu of the company’s monthly dividend based on Parker’s election. After this transaction, Parker beneficially owned 106,420 deferred stock units, held directly. These units are fully vested but will be paid only upon a change of control or upon Parker’s death, disability, or separation from service as a director.
Orchid Island Capital, Inc. director Frank P. Filipps reported an equity compensation transaction involving deferred stock units. On 01/02/2026, he acquired 3,472 deferred stock units, each representing the right to receive one share of Orchid Island Capital common stock. The filing shows these units at a price of $0, reflecting a grant rather than an open-market purchase.
After this grant, Filipps beneficially owns 46,728 deferred stock units, held in direct ownership form. The units are fully vested but will only be paid out in common shares upon the earlier of a change of control of the company or his death, disability, or separation from service as a director. This filing documents the update to his equity-based holdings.
Orchid Island Capital director reports additional deferred stock units. A director of Orchid Island Capital, Inc. acquired derivative equity awards in the form of deferred stock units tied to the company’s common stock.
On 12/30/2025, the director received 1,644 deferred stock units at a price of $7.28 per underlying share. On 01/02/2026, the director received another 3,472 deferred stock units at a price of $0, bringing total derivative securities beneficially owned to 104,861 deferred stock units.
Each deferred stock unit represents the right to receive one share of common stock and is fully vested. These units, including those issued in lieu of the company’s monthly dividend at the director’s election, become payable upon a change of control or the director’s death, disability, or separation from service as a director.
Orchid Island Capital, Inc. reported that one of its directors received 3,472 deferred stock units on 01/02/2026. Each deferred stock unit represents the right to receive one share of Orchid Island Capital common stock. After this grant, the director beneficially owns 48,539 derivative securities in the form of deferred stock units, held directly.
The deferred stock units are fully vested but will only be paid out in common shares upon the earlier of a change of control of the company, or the director’s death, disability, or separation from service as a director. This structure ties the director’s equity value to the company’s long-term performance and continuity of service.
Orchid Island Capital, Inc. reported a routine insider equity award for one of its directors. On 01/02/2026, the director acquired 3,472 deferred stock units at a price of $0 per unit, as shown in the derivative securities table. Each deferred stock unit represents the right to receive one share of Orchid Island Capital common stock.
The deferred stock units are fully vested but will only be paid out upon a change of control of the company or the director’s death, disability, or separation from service as a director. Following this transaction, the director beneficially owns 46,728 derivative securities in the form of deferred stock units, held directly.
Orchid Island Capital, Inc. reports that Chief Executive Officer Robert E. Cauley exercised 3,694.18 Performance Units into common stock on December 26, 2025, following awards granted in 2023 and 2024 under the company’s equity incentive plans. In connection with this vesting, 753 common shares were delivered back to the issuer at $7.35 per share to satisfy tax-withholding obligations, a price equal to the December 24, 2025 closing price. After these transactions, Cauley directly holds 147,495 shares of Orchid Island common stock.
Orchid Island Capital, Inc. director and Chief Financial Officer G. Hunter Haas IV reported equity award activity in company stock. On 12/26/2025, performance units converted into 3,031 shares of common stock at an exercise price of $0, reflecting vesting of prior awards under the company’s equity incentive plans. On the same date, he disposed of 1,133 shares back to the company at $7.35 per share to cover tax withholding related to the vesting. Following these transactions, he directly holds 77,498 shares of common stock and 10,819.39 performance units.
Orchid Island Capital, Inc. director Ava Parker reported receiving 1,615 deferred stock units on 11/28/2025. Each deferred stock unit represents one share of Orchid Island Capital common stock and was issued in lieu of the company’s monthly dividend under Parker’s prior election. The units are fully vested but will not be paid out until the earlier of a change of control or Parker’s death, disability, or separation from service as a director. Following this transaction, Parker beneficially owns 99,745 derivative securities in the form of deferred stock units, held directly.
Orchid Island Capital (ORC) disclosed a director’s Form 4 showing the acquisition of 1,494 deferred stock units on 10/31/2025 at $7.31 per unit. The filing states these units were issued in lieu of the issuer’s monthly dividend per the reporting person’s election.
Each deferred stock unit equals one share of common stock and is 100% vested, but becomes payable upon the earlier of a change of control or the director’s death, disability, or separation from service. Following the transaction, derivative securities beneficially owned were 98,130, held directly.
Frank P. Filipps, a director of Orchid Island Capital, Inc. (ORC), reported a Form 4 showing he was granted 3,566 deferred stock units on 10/01/2025. Each deferred stock unit represents a right to receive one share of the company’s common stock and the units are stated to be 100% vested. The deferred units do not become payable until the earlier of a change of control or the reporting person’s death, disability, or separation from service as a director. After this grant, the Form 4 reports total beneficial ownership of 43,256 shares. The filing was signed on 10/02/2025.
Orchid Island Capital director Paula Morabito reported acquiring 3,566 deferred stock units on 10/01/2025. Each unit equals one share of common stock and the units are 100% vested, but payment is deferred until the earlier of a change of control, the reporting person's death or disability, or separation from service as a director. After this transaction, the reporting person beneficially owns 45,067 shares of Orchid Island Capital common stock. The filing is a Form 4 reporting an insider non-derivative acquisition of deferred compensation units.
W. Coleman Bitting, a director of Orchid Island Capital, Inc. (ORC), reported receiving 3,566 deferred stock units on 10/01/2025. Each unit represents a right to one share of the company's common stock and carries a stated price of $0. After this grant, Mr. Bitting beneficially owns 43,256 shares (direct). The deferred stock units are fully vested but are payable only upon a specified triggering event: the earlier of a change of control or the reporting person’s death, disability, or separation from service as a director. The Form is signed on 10/02/2025.
Ava L. Parker, a director of Orchid Island Capital, Inc. (ORC), reported three grants of deferred stock units on 09/30/2025 and 10/01/2025.
The filings show 1,553 DSUs issued on 09/30/2025 in lieu of the monthly dividend at an attributable value of $6.91 per unit, plus two grants on 10/01/2025 of 3,566 DSUs (no price listed) and 2,050 DSUs granted in lieu of cash compensation with an attributable value of $7.01 per unit. Following these transactions the reporting person beneficially owned 96,636 shares.
The DSUs are fully vested but payable only upon a change of control or the reporting person's death, disability, or separation from service as a director.
Orchid Island Capital director and CFO G. Hunter Haas, IV reported transactions on 09/26/2025 reflecting the vesting of Performance Units and a related withholding sale. 3,031.72 Performance Units vested and were converted into 3,031 shares of common stock (cash paid for fractional shares). To satisfy tax withholding on the vesting, 1,133 shares were transferred back to the issuer at a closing price of $6.99 per share. After these transactions the reporting person directly beneficially owned 75,600 shares of common stock and held performance-unit-based derivative interests equal to 3,031.72 underlying shares, with 13,851.11 derivative securities reported as beneficially owned following the transactions.
Orchid Island Capital CEO Robert E. Cauley reported vesting-related share activity. Performance Units vested into 3,694 shares of common stock from awards granted in 2023 and 2024. Separately, 742 shares were surrendered to the company for tax withholding at $6.99 per share. After these events, he directly holds 144,554 common shares.